Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transforming Growth Factor beta1 | 4 | 2021 | 126 | 1.080 |
Why?
|
| Heart | 5 | 2014 | 850 | 1.050 |
Why?
|
| Transforming Growth Factor beta2 | 6 | 2021 | 19 | 1.040 |
Why?
|
| Mice, Knockout | 6 | 2014 | 1692 | 0.800 |
Why?
|
| Cell Movement | 5 | 2021 | 630 | 0.770 |
Why?
|
| Emodin | 1 | 2021 | 21 | 0.760 |
Why?
|
| Cell Proliferation | 3 | 2021 | 1174 | 0.710 |
Why?
|
| Fibroblasts | 3 | 2021 | 902 | 0.670 |
Why?
|
| Transforming Growth Factor beta | 4 | 2009 | 384 | 0.570 |
Why?
|
| beta Catenin | 1 | 2017 | 73 | 0.560 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2016 | 328 | 0.560 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 57 | 0.550 |
Why?
|
| Transforming Growth Factor beta3 | 2 | 2012 | 16 | 0.490 |
Why?
|
| Mesoderm | 4 | 2020 | 231 | 0.490 |
Why?
|
| Alleles | 2 | 2014 | 386 | 0.490 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 163 | 0.480 |
Why?
|
| Heart Valves | 2 | 2017 | 171 | 0.480 |
Why?
|
| Myocardium | 5 | 2021 | 1204 | 0.450 |
Why?
|
| Heart Defects, Congenital | 1 | 2016 | 596 | 0.370 |
Why?
|
| Smad2 Protein | 4 | 2021 | 42 | 0.370 |
Why?
|
| Smad3 Protein | 2 | 2021 | 33 | 0.290 |
Why?
|
| Extracellular Matrix | 4 | 2019 | 493 | 0.290 |
Why?
|
| Epithelial Cells | 1 | 2009 | 431 | 0.280 |
Why?
|
| Animals | 15 | 2021 | 20880 | 0.270 |
Why?
|
| Cell Differentiation | 6 | 2014 | 1034 | 0.260 |
Why?
|
| Mice | 11 | 2021 | 8474 | 0.260 |
Why?
|
| Signal Transduction | 6 | 2021 | 2689 | 0.250 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2003 | 40 | 0.230 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2020 | 317 | 0.230 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2020 | 144 | 0.220 |
Why?
|
| Endothelial Cells | 2 | 2020 | 384 | 0.210 |
Why?
|
| Collagen | 3 | 2021 | 636 | 0.210 |
Why?
|
| Pancreatic Elastase | 1 | 2021 | 33 | 0.200 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2021 | 10 | 0.200 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2012 | 209 | 0.190 |
Why?
|
| Phenotype | 2 | 2016 | 946 | 0.190 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 134 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 150 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 147 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 2791 | 0.180 |
Why?
|
| Neointima | 1 | 2020 | 7 | 0.180 |
Why?
|
| Jugular Veins | 1 | 2020 | 37 | 0.180 |
Why?
|
| Fibrosis | 1 | 2021 | 371 | 0.170 |
Why?
|
| Isothiocyanates | 1 | 2019 | 10 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2021 | 2083 | 0.170 |
Why?
|
| Gene Dosage | 2 | 2016 | 47 | 0.160 |
Why?
|
| Neural Crest | 3 | 2006 | 58 | 0.140 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2016 | 15 | 0.140 |
Why?
|
| Cells, Cultured | 1 | 2021 | 2673 | 0.130 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2013 | 56 | 0.130 |
Why?
|
| Ligands | 2 | 2009 | 317 | 0.130 |
Why?
|
| beta-Galactosidase | 1 | 2014 | 88 | 0.120 |
Why?
|
| Heterozygote | 1 | 2014 | 174 | 0.120 |
Why?
|
| Mutation | 2 | 2021 | 1213 | 0.120 |
Why?
|
| Genotype | 1 | 2016 | 785 | 0.110 |
Why?
|
| Neurofibromatosis 1 | 1 | 2013 | 39 | 0.110 |
Why?
|
| Aorta, Thoracic | 2 | 2006 | 211 | 0.110 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 135 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2013 | 145 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 2550 | 0.100 |
Why?
|
| Exons | 1 | 2012 | 122 | 0.100 |
Why?
|
| Cleft Palate | 1 | 2012 | 34 | 0.100 |
Why?
|
| Male | 4 | 2021 | 37283 | 0.100 |
Why?
|
| Aorta, Abdominal | 1 | 2011 | 97 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 1533 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 208 | 0.100 |
Why?
|
| Angiotensin II | 1 | 2011 | 220 | 0.090 |
Why?
|
| Antigens, Differentiation | 1 | 2009 | 49 | 0.090 |
Why?
|
| Apoptosis | 2 | 2014 | 1641 | 0.080 |
Why?
|
| Pericardium | 1 | 2009 | 97 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1174 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2009 | 199 | 0.080 |
Why?
|
| Embryonic Induction | 1 | 2004 | 19 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 2004 | 109 | 0.060 |
Why?
|
| Female | 3 | 2021 | 38021 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2004 | 119 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2003 | 64 | 0.060 |
Why?
|
| Epithelium | 1 | 2003 | 172 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2004 | 237 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 176 | 0.050 |
Why?
|
| Nestin | 1 | 2021 | 6 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 700 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2021 | 168 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2020 | 89 | 0.050 |
Why?
|
| Vascular Remodeling | 1 | 2020 | 34 | 0.040 |
Why?
|
| Aorta | 1 | 2021 | 316 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 213 | 0.040 |
Why?
|
| Sulfoxides | 1 | 2019 | 16 | 0.040 |
Why?
|
| Heme Oxygenase-1 | 1 | 2019 | 40 | 0.040 |
Why?
|
| Kidney | 1 | 2003 | 945 | 0.040 |
Why?
|
| Integrins | 1 | 2019 | 115 | 0.040 |
Why?
|
| Hydrogels | 1 | 2019 | 54 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2019 | 149 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 444 | 0.040 |
Why?
|
| Humans | 5 | 2021 | 68549 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 144 | 0.040 |
Why?
|
| Cattle | 1 | 2019 | 475 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2019 | 223 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 1033 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2009 | 146 | 0.040 |
Why?
|
| Neurofibromin 1 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2013 | 25 | 0.030 |
Why?
|
| Integrases | 1 | 2013 | 31 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2013 | 14 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 97 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2013 | 145 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2013 | 99 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 160 | 0.030 |
Why?
|
| ras Proteins | 1 | 2013 | 102 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 92 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2011 | 368 | 0.020 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2011 | 139 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 981 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2009 | 158 | 0.020 |
Why?
|
| Heart Atria | 1 | 2009 | 206 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 442 | 0.020 |
Why?
|
| Birds | 1 | 2006 | 17 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2009 | 738 | 0.020 |
Why?
|
| CD56 Antigen | 1 | 2004 | 3 | 0.020 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2004 | 4 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 2004 | 32 | 0.020 |
Why?
|
| Models, Animal | 1 | 2006 | 252 | 0.020 |
Why?
|
| Wnt1 Protein | 1 | 2004 | 9 | 0.020 |
Why?
|
| Subclavian Artery | 1 | 2004 | 30 | 0.020 |
Why?
|
| Sinoatrial Node | 1 | 2004 | 14 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2004 | 57 | 0.010 |
Why?
|
| Atrioventricular Node | 1 | 2004 | 39 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 191 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 146 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 376 | 0.010 |
Why?
|
| Biomarkers | 1 | 2004 | 1593 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 1293 | 0.010 |
Why?
|